Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient
Clinical trial NCT03222843 · COMPLETED
Trial details
- NCT number
- NCT03222843
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2019-11-11
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.